Products

Our lead products Curi01 and Curi02 developed on
the SIOTWO® platform, are designed to:

Regulate excess wound
exudate

Enable faster transition to
granulation and healing

Integrate easily into
hospital workflows

DFU serves as the clinical and commercial
validation of the SIOTWO® platform, while
establishing a clear path to further indications.

What are the USP’s of our lead products:

Managing the gap

When exudate accumulates in the gap between the wound bed and the dressing, it’s called exudate pooling. This is a challenge in wounds with irregular topographies, cavities or pockets. Dressings cannot reach the exudate in these topographies - thus wound healing cannot start. Our powders behave like a magic fluid what can easily reach these pockets and start working from there.

Efficient impact

The strong capillary effect leads to efficient absorption of excessive wound exudate and allows binding of inflammatory cells. Cell formation is stimulated, and an optimal moisturizing environment is re-established.

Cost savings

Due to affordable pricing and higher efficacy, Curi01/Curi02 will reduce duration and cost of treatment.

Simplicity